News 2018-04-19T19:24:31+00:00

In The News

OICR’s Cancer Therapeutics Innovation Pipeline initiative funds M4K’s ALK2 program for DIPG as part of the inaugural set of projects

December 4th, 2017|

OICR's Cancer Therapeutics Innovation Pipeline initiative funds M4K's ALK2 program for DIPG as part of the inaugural set of projects The Ontario Institute for Cancer Research (OICR) announced its Cancer Therapeutics [...]